Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis

Authors

  • Tomonori Oka
  • Makoto Sugaya
  • Naomi Takahashi
  • Rina Nakajima
  • Sayaka Otobe
  • Miyoko Kabasawa
  • Hiraku Suga
  • Tomomitsu Miyagaki
  • Yoshihide Asano
  • Shinichi Sato

DOI:

https://doi.org/10.2340/00015555-2723

Keywords:

IL-19, atopic dermatitis, cutaneous T-cell lymphoma, keratinocytes, IL-4, IL-17A

Abstract

Interleukin-19 (IL-19), a pro-inflammatory cytokine known to stimulate the production of T helper type 2 (Th2) cytokines, is induced by IL-17A and highly expressed in the lesional skin of psoriasis and atopic dermatitis (AD). This aim of this study was to investigate whether IL-19 is involved in cutaneous T-cell lym?phoma (CTCL) and AD. IL-19 levels were significantly higher in the sera of patients with AD and those with advanced-stage CTCL than in normal controls, correlating significantly with clinical disease markers. IL-19 mRNA levels in lesional skin of both diseases were significantly elevated. Immunohistochemical staining revealed that IL-19 was expressed in the epidermis of AD skin and CTCL skin. In vitro, IL-17A and IL-4 increased IL-19 mRNA expression in human keratinocytes. Thus, IL-19 was increased in the sera and skin of AD and CTCL. These results suggest that IL-19 is important for bridging Th17 to Th2 in these diseases.

Downloads

Download data is not yet available.

Downloads

Published

2017-08-23

How to Cite

Oka, T., Sugaya, M., Takahashi, N., Nakajima, R., Otobe, S., Kabasawa, M., … Sato, S. (2017). Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis. Acta Dermato-Venereologica, 97(10), 1172–1177. https://doi.org/10.2340/00015555-2723

Issue

Section

Articles